Mirae Asset Global Investments Co., Ltd. Bei Gene, Ltd. Transaction History

Mirae Asset Global Investments Co., Ltd.

$28 Billion
Q2 2025

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,824 shares of BGNE stock, worth $866,939. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,824

Previous 3,450 10.84%

Holding current value

$866,939

Previous $782,000 10.74%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 21, 2025	BUY	N/A	374 Added 10.84%	3,824 $866,000
Q1 2025 Apr 24, 2025	BUY	$175.1 - $226.71 $10,856 - $14,056	62 Added 1.83%	3,450 $782,000
Q4 2024 Jan 27, 2025	SELL	$174.72 - $246.04 $62,375 - $87,836	-357 Reduced 9.53%	3,388 $625,000
Q3 2024 Oct 23, 2024	SELL	$143.93 - $224.51 $61,602 - $96,090	-428 Reduced 10.26%	3,745 $840,000
Q2 2024 Jul 30, 2024	BUY	$129.52 - $174.32 $540,486 - $727,437	4,173 New	4,173 $595,000
Q1 2023 May 04, 2023	BUY	$215.53 - $274.5 $2.41 Million - $3.07 Million	11,166 New	11,166 $2.41 Million
Q3 2022 Nov 10, 2022	SELL	$131.8 - $202.24 $10.5 Million - $16.1 Million	-79,743 Reduced 86.78%	12,148 $1.64 Million
Q2 2022 Jul 26, 2022	SELL	$121.11 - $216.05 $817,250 - $1.46 Million	-6,748 Reduced 6.84%	91,891 $14.9 Million
Q1 2022 May 10, 2022	SELL	$146.52 - $269.56 $2.32 Million - $4.27 Million	-15,832 Reduced 13.83%	98,639 $18.6 Million
Q4 2021 Feb 08, 2022	SELL	$248.56 - $389.34 $5.42 Million - $8.49 Million	-21,803 Reduced 16.0%	114,471 $31 Million
Q3 2021 Nov 15, 2021	SELL	$249.6 - $403.14 $5.57 Million - $8.99 Million	-22,300 Reduced 14.06%	136,274 $49.5 Million
Q2 2021 Aug 11, 2021	SELL	$292.75 - $367.01 $409,850 - $513,814	-1,400 Reduced 0.88%	158,574 $54.4 Million
Q1 2021 May 13, 2021	BUY	$260.64 - $382.12 $13.9 Million - $20.5 Million	53,520 Added 50.28%	159,974 $55.7 Million
Q4 2020 Feb 10, 2021	BUY	$221.31 - $316.61 $2.11 Million - $3.02 Million	9,535 Added 9.84%	106,454 $27.5 Million
Q3 2020 Nov 12, 2020	BUY	$189.18 - $286.44 $9.85 Million - $14.9 Million	52,074 Added 116.12%	96,919 $27.8 Million
Q2 2020 Aug 11, 2020	BUY	$123.9 - $195.41 $125,510 - $197,950	1,013 Added 2.31%	44,845 $8.45 Million
Q1 2020 May 12, 2020	SELL	$121.84 - $173.19 $2.07 Million - $2.95 Million	-17,005 Reduced 27.95%	43,832 $5.4 Million
Q4 2019 Feb 12, 2020	BUY	$115.78 - $208.34 $165,681 - $298,134	1,431 Added 2.41%	60,837 $10.1 Million
Q3 2019 Nov 12, 2019	BUY	$120.61 - $148.29 $7.16 Million - $8.81 Million	59,406 New	59,406 $7.27 Million
Q2 2019 Aug 13, 2019	SELL	$113.99 - $146.86 $188,311 - $242,612	-1,652 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$122.82 - $151.83 $202,898 - $250,823	1,652 New	1,652 $218,000

Others Institutions Holding BGNE

# of Institutions

282

Shares Held

35.8M

Call Options Held

110K

Put Options Held

111K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $23.5B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Bei Gene, Ltd. Transaction History